1-1 of 1
Yanrong Dong
Close
Sort by
Journal Articles

CG001, a C3b-targeted complement inhibitor blocks three complement pathways: development and preclinical evaluation

Ling Li, Peipei Ding, Yanrong Dong, Shupei Shen, Xinyue Lv, Jie Yu, Luying Li, Jianfeng Chen, Pilin Wang, Bing Han, Ting Xu, Weiguo Hu
Journal: Blood Advances
Blood Adv bloodadvances.2024012874.
https://doi.org/10.1182/bloodadvances.2024012874
Published: 2024
Includes: Supplemental data